Tokyo Tape
Sign in
← Stella Pharma

Annual report

4888.TEDINET S100R76K
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 75
MetricValuePeriodScopeSource row
Revenue¥229m2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥100m2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥206m2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Operating income−¥807m2022-04-01 → 2023-03-31StandaloneOperating income
Operating income−¥742m2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income−¥776m2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income−¥764m2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income−¥656m2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥959m2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥856m2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥776m2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax−¥764m2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income−¥779m2022-04-01 → 2023-03-31StandaloneProfit loss
Net income−¥768m2021-04-01 → 2022-03-31StandaloneProfit loss
Net income−¥659m2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income−¥962m2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income−¥859m2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Total assets¥4.3bnat 2023-03-31StandaloneAssets
Total assets¥4.7bnat 2022-03-31StandaloneAssets
Total assets¥2.0bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.7bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.6bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.6bnat 2023-03-31StandaloneLiabilities
Total liabilities¥1.6bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥2.8bnat 2023-03-31StandaloneNet assets
Net assets / equity¥3.1bnat 2022-03-31StandaloneNet assets
Net assets / equity¥231mat 2021-03-31dStandaloneNet assets
Net assets / equity¥690mat 2020-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.7bnat 2019-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥2.7bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥3.3bnat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥2.7bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥838mat 2021-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.0bnat 2020-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.4bnat 2019-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥828m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥773m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥914m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥771m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥30m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥351m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥23m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥1.6bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥15m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥292m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥3.8bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥332m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥69m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-26.972022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-27.342021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-32.92020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-61.682019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.282018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥91.51at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥107.39at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥11.46at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥34.57at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥-142.57at 2019-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio63.3%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio65.3%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio11.3%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio25.9%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio45.6%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued29,966,300at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,676,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued20,137,400at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued19,960,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued129,600at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees46at 2023-03-31StandaloneNumber of employees
Employees43at 2022-03-31StandaloneNumber of employees
Employees43at 2021-03-31dStandaloneNumber of employees
Employees42at 2020-03-31dStandaloneNumber of employees
Employees36at 2019-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 817
ItemContextValueUnit
Company name cover pageFilingDateInstant
Original text (Japanese)ステラファーマ株式会社
Company name in english cover pageFilingDateInstantSTELLA PHARMA CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　上原　幸樹
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)大阪市中央区高麗橋三丁目２番７号　ＯＲＩＸ高麗橋ビル
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)(06)4707-1516（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員総務部長　小川　礼隆
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)大阪市中央区高麗橋三丁目２番７号　ＯＲＩＸ高麗橋ビル
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)(06)4707-1516（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員総務部長　小川　礼隆
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE35496
Fund codeFilingDateInstant－
Security codeFilingDateInstant48880
Filer name in japaneseFilingDateInstant
Original text (Japanese)ステラファーマ株式会社
Filer name in englishFilingDateInstantSTELLA PHARMA CORPORATION
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Current fiscal year start dateFilingDateInstant2022-04-01
Current period end dateFilingDateInstant2023-03-31
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2023-03-31
Previous fiscal year start dateFilingDateInstant2021-04-01
Comparative period end dateFilingDateInstant2022-03-31
Previous fiscal year end dateFilingDateInstant2022-03-31
Next fiscal year start dateFilingDateInstant－
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant－
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of reporting company (text)FilingDateInstantText · Plus
Company history (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Overview of affiliated entities (text)FilingDateInstantText · Plus
Information about employees (text)FilingDateInstantText · Plus
Business policy business environment issues to address etc (text)FilingDateInstantText · Plus
Disclosure of sustainability related financial information (text)FilingDateInstantText · Plus
Governance (text)FilingDateInstantText · Plus
Strategy (text)FilingDateInstantText · Plus
Policy on human resource development and improvement of internal environment strategy (text)FilingDateInstantText · Plus
Risk management (text)FilingDateInstantText · Plus
Metrics and targets (text)FilingDateInstantText · Plus
Description of metrics related to policy on human resource development and improvement of internal environment and targets and results using such metrics metrics and targets (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2022-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass